Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Campanati

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Biomedicines|May 28, 2022
The Challenge Arising from New Knowledge about Immune and Inflammatory Skin Diseases: Where We Are Today and Where We Are GoingAnna Campanati, Emanuela Martina, Annamaria Offidani
World Journal of Hepatology|April 8, 2015
Non-alcoholic fatty liver disease and psoriasis: So far, so nearGiulia Ganzetti, Anna Campanati, Annamaria Offidani
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica|March 30, 2017
Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox?Emanuela Martina, Anna Campanati, Katia Giuliodori, et al.
Skin Health and Disease|March 24, 2025
A case of pembrolizumab-induced bullous pemphigoid treated with dupilumabAgnese Rossi, Donatella Brancorsini, Helena Gioacchini, et al.
Current Pharmaceutical Biotechnology|February 10, 2018
Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- α InhibitorsAnna Campanati, Elisa Molinelli, Valerio Brisigotti, et al.
Current Pharmaceutical Biotechnology|January 5, 2018
Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 PathwaysElisa Molinelli, Anna Campanati, Valerio Brisigotti, et al.
World Journal of Cardiology|March 17, 2016
Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique backgroundGiulia Ganzetti, Anna Campanati, Elisa Molinelli, et al.
Journal of Clinical Medicine|February 13, 2020
Saliva and Oral DiseasesEmanuela Martina, Anna Campanati, Federico Diotallevi, et al.
Skin Appendage Disorders|May 13, 2016
Oxybutynin for the Treatment of Primary Hyperhidrosis: Current State of the ArtAnna Campanati, Stamatis Gregoriou, George Kontochristopoulos, et al.
Current Drug Safety|October 15, 2015
Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety ProfileGiulia Ganzetti, Anna Campanati, E Molinelli, et al.
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Biomedicines|May 28, 2022
The Challenge Arising from New Knowledge about Immune and Inflammatory Skin Diseases: Where We Are Today and Where We Are GoingAnna Campanati, Emanuela Martina, Annamaria Offidani
World Journal of Hepatology|April 8, 2015
Non-alcoholic fatty liver disease and psoriasis: So far, so nearGiulia Ganzetti, Anna Campanati, Annamaria Offidani
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica|March 30, 2017
Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox?Emanuela Martina, Anna Campanati, Katia Giuliodori, et al.
Skin Health and Disease|March 24, 2025
A case of pembrolizumab-induced bullous pemphigoid treated with dupilumabAgnese Rossi, Donatella Brancorsini, Helena Gioacchini, et al.
Current Pharmaceutical Biotechnology|February 10, 2018
Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- α InhibitorsAnna Campanati, Elisa Molinelli, Valerio Brisigotti, et al.
Current Pharmaceutical Biotechnology|January 5, 2018
Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 PathwaysElisa Molinelli, Anna Campanati, Valerio Brisigotti, et al.
World Journal of Cardiology|March 17, 2016
Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique backgroundGiulia Ganzetti, Anna Campanati, Elisa Molinelli, et al.
Journal of Clinical Medicine|February 13, 2020
Saliva and Oral DiseasesEmanuela Martina, Anna Campanati, Federico Diotallevi, et al.
Skin Appendage Disorders|May 13, 2016
Oxybutynin for the Treatment of Primary Hyperhidrosis: Current State of the ArtAnna Campanati, Stamatis Gregoriou, George Kontochristopoulos, et al.
Current Drug Safety|October 15, 2015
Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety ProfileGiulia Ganzetti, Anna Campanati, E Molinelli, et al.
Pageof 16